Evidence map›Paper›PMID 36628054›Full record

ArticleOpen forum infectious diseases2023

Persistent Symptoms and Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection Not Requiring Hospitalization: Results From Testing Denmark, a Danish Cross-sectional Survey.

Maarten van Wijhe, Kamille Fogh, Steen Ethelberg, Kasper Karmark Iversen, Henrik Nielsen, Lars Østergaard, Berit Andersen, Henning Bundgaard, Charlotte S Jørgensen, Bibi F Ss Scharff and 19 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 8 institutions in 1 country.

Maarten van WijheDepartment of Science and Environment, Roskilde University, Roskilde, Denmark.ORCID https://orcid.org/0000-0001-9216-8393
Kamille FoghDepartment of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark.ORCID https://orcid.org/0000-0002-6669-6894
Steen EthelbergStatens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-9709-356X
Kasper Karmark IversenDepartment of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark.ORCID https://orcid.org/0000-0003-0504-8487
Henrik NielsenDepartment of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark.ORCID https://orcid.org/0000-0002-0841-8255
Lars ØstergaardStatens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0003-2459-0511
Berit AndersenStatens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0003-4074-6504
Henning BundgaardDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-0563-7049
Charlotte S JørgensenStatens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-7156-1986
Bibi F Ss ScharffDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Denmark.
Svend Ellermann-EriksenStatens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0001-9324-911X
Isik S JohansenDepartment of Infectious Diseases, Odense University Hospital, Odense, Denmark.ORCID https://orcid.org/0000-0002-2189-9823
Anders FomsgaardStatens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0003-4304-0603
Tyra Grove KrauseStatens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0001-6286-5999
Lothar WieseDepartment of Infectious Diseases, Zealand University Hospital, Roskilde, Denmark.ORCID https://orcid.org/0000-0003-2719-1743
Thea K FischerDepartment of Public Health, University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0003-4812-980X
Kåre MølbakStatens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-3100-4990
Thomas BenfieldDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0003-0698-9385
Fredrik FolkeDepartment of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark.ORCID https://orcid.org/0000-0002-2284-7857
Freddy LippertDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-2356-8809
Sisse R OstrowskiDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0001-5288-3851
Anders KochStatens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0001-9205-1048
Christian ErikstrupDepartment of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.ORCID https://orcid.org/0000-0001-6551-6647
Anne-Marie VangstedStatens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0001-5925-6607
Anna Irene Vedel SørensenStatens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-3877-4592
Henrik UllumStatens Serum Institut, Copenhagen, Denmark.ORCID https://orcid.org/0000-0001-7306-9058
Robert Leo SkovStatens Serum Institut, Copenhagen, Denmark.
Lone SimonsenDepartment of Science and Environment, Roskilde University, Roskilde, Denmark.ORCID https://orcid.org/0000-0003-1535-8526
Susanne Dam NielsenDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0001-6391-7455
Statens Serum Institut · DKUniversity of Copenhagen · DKRoskilde University · DKAalborg University Hospital · DKAarhus University Hospital · DKCopenhagen University Hospital · DKUniversity of Southern Denmark · DKZealand University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with persistent symptoms ("long COVID"). We assessed the burden of long COVID among nonhospitalized adults with polymerase chain reaction (PCR)-confirmed SARS-CoV-2 infection. Methods: In the fall of 2020, a cross-sectional survey was performed in the adult Danish general population. This included a self-administered point-of-care test for SARS-CoV-2 antibodies, the Short Form Health Survey (SF-12), and coronavirus disease 2019 (COVID-19)-associated symptom questions. Nonhospitalized respondents with a positive SARS-CoV-2 PCR test ≥12 weeks before the survey (cases) were matched (1:10) to seronegative controls on age, sex, and body mass index. Propensity score-weighted odds ratios (ORs) and ORs for risk factors were estimated for each health outcome. Results: In total, 742 cases and 7420 controls were included. The attributable risk of at least 1 long-COVID symptom was 25.0 per 100 cases (95% confidence interval [CI], 22.2-27.4). Compared to controls, cases reported worse general health (OR, 5.9 [95% CI, 5.0-7.0]) and had higher odds for a broad range of symptoms, particularly loss of taste (OR, 11.8 [95% CI, 9.5-14.6]) and smell (OR, 11.2 [95% CI, 9.1-13.9]). Physical and Mental Component Summary scores were also significantly reduced with differences of -2.5 (95% CI, -3.1 to -1.8) and -2.0 (95% CI, -2.7 to -1.2), respectively. Female sex and severity of initial infection were major risk factors for long COVID. Conclusions: Nonhospitalized SARS-CoV-2 PCR-positive individuals had significantly reduced physical and mental health, and 1 in 4 reported persistence of at least 1 long-COVID symptom.

Indexed as

COVID-19cross-sectional studyhealth-related quality-of-lifelong COVIDnonhospitalized patients

Identifiers

PMID36628054
PMCPMC9825266
OpenAlexW4312072391

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.